OR WAIT null SECS
February 01, 2019
The acquisition will boost Hitachi Chemical’s presence in the European regenerative medicines market.
January 22, 2019
The acquisition of biopharmaceutical company TESARO is expected to strengthen GSK’s oncology pipeline and commercial footprint.
January 08, 2019
The $8-billion acquisition will broaden Lilly's oncology portfolio in precision medicines and treatments that target cancers caused by specific gene abnormalities.
January 03, 2019
The $252-million acquisition is expected to strengthen Cambrex’s position as a small-molecule CDMO across the drug lifecycle.
Merger cites combined strengths in oncology, immunology and inflammation, and cardiovascular disease.
December 21, 2018
The $2.1-billion acquisition strengthens Novartis’ position in nuclear medicine and radioligand therapy for treating cancer.
December 19, 2018
The proposed $12.7-billion deal includes the spinoff of GSK and Pfizer consumer brands to a new UK-listed company.
December 14, 2018
Roquette has announced the completion of its acquisition of a majority stake in a pharma packaging company based in India.
Capital Recovery Group, Federal Equipment Company, Heritage Global Partners, and PPL Group purchased a 110-acre campus with a flexible pharmaceutical manufacturing and packaging facility from a generics manufacturer in Huntsville, AL.
The merged companies will provide histopathology services in the research and pre-clinical therapeutics markets.